Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua S Harris

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 8, 2025
Applicability domain-expansion studies for machine learning models reveal new inhibitors of CYP2B6Patricia A Vignaux, Joshua S Harris, Fabio Urbina, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2025
DDI-CYP: Metabolism ensemble models for drug-drug interaction predictionsJason T Wong, Joshua S Harris, Thomas R Lane, et al.
ACS Chemical Neuroscience|May 14, 2025
Adverse Outcome Pathway and Machine Learning to Predict Drug Induced Seizure LiabilityThomas R Lane, Scott H Snyder, Joshua S Harris, et al.
ACS Chemical Neuroscience|August 2, 2024
Predicting the Hallucinogenic Potential of Molecules Using Artificial IntelligenceFabio Urbina, Thane Jones, Joshua S Harris, et al.
Environmental Science & Technology|June 27, 2025
Machine Learning and Large Language Models for Modeling Complex Toxicity Pathways and Predicting SteroidogenesisThomas R Lane, Patricia A Vignaux, Joshua S Harris, et al.
Journal of Chemical Information and Modeling|July 16, 2024
Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug DiscoveryMatthew A Dorsey, Kelvin Dsouza, Dhruv Ranganath, et al.
Artificial Intelligence in the Life Sciences|January 14, 2026
MegaEye: Applying multiple machine learning approaches to identify oral compounds with ocular bioactivityFabio Urbina, Scott H Greenwald, Patricia A Vignaux, et al.
Molecular Pharmaceutics|March 20, 2025
Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)Lucy Martinez-Guerrero, Patricia A Vignaux, Joshua S Harris, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 19, 2025
Machine Learning Modeling of Zebrafish Toxicity Endpoints After Exposure to PROTACsChristopher Yogodzinski, Joshua S Harris, Thomas R Lane, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 6, 2026
MegaTrans-machine learning models for drug transporters corresponding to the FDA guidancePatricia A Vignaux, Melanie Tojong, Alexander Kyu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 8, 2025
Applicability domain-expansion studies for machine learning models reveal new inhibitors of CYP2B6Patricia A Vignaux, Joshua S Harris, Fabio Urbina, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2025
DDI-CYP: Metabolism ensemble models for drug-drug interaction predictionsJason T Wong, Joshua S Harris, Thomas R Lane, et al.
ACS Chemical Neuroscience|May 14, 2025
Adverse Outcome Pathway and Machine Learning to Predict Drug Induced Seizure LiabilityThomas R Lane, Scott H Snyder, Joshua S Harris, et al.
ACS Chemical Neuroscience|August 2, 2024
Predicting the Hallucinogenic Potential of Molecules Using Artificial IntelligenceFabio Urbina, Thane Jones, Joshua S Harris, et al.
Environmental Science & Technology|June 27, 2025
Machine Learning and Large Language Models for Modeling Complex Toxicity Pathways and Predicting SteroidogenesisThomas R Lane, Patricia A Vignaux, Joshua S Harris, et al.
Journal of Chemical Information and Modeling|July 16, 2024
Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug DiscoveryMatthew A Dorsey, Kelvin Dsouza, Dhruv Ranganath, et al.
Artificial Intelligence in the Life Sciences|January 14, 2026
MegaEye: Applying multiple machine learning approaches to identify oral compounds with ocular bioactivityFabio Urbina, Scott H Greenwald, Patricia A Vignaux, et al.
Molecular Pharmaceutics|March 20, 2025
Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)Lucy Martinez-Guerrero, Patricia A Vignaux, Joshua S Harris, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 19, 2025
Machine Learning Modeling of Zebrafish Toxicity Endpoints After Exposure to PROTACsChristopher Yogodzinski, Joshua S Harris, Thomas R Lane, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 6, 2026
MegaTrans-machine learning models for drug transporters corresponding to the FDA guidancePatricia A Vignaux, Melanie Tojong, Alexander Kyu, et al.
Pageof 2